Mutares, Walks

Mutares Walks a Tightrope Between Debt Discipline and Its Biggest-Ever Acquisition

29.04.2026 - 13:21:52 | boerse-global.de

Mutares breaches debt covenants, secures bondholder waiver, and outlines a repayment roadmap while pursuing a record SABIC acquisition and exploring strategic options for Magirus.

Mutares Walks a Tightrope Between Debt Discipline and Its Biggest-Ever Acquisition - Foto: ĂĽber boerse-global.de
Mutares Walks a Tightrope Between Debt Discipline and Its Biggest-Ever Acquisition - Foto: ĂĽber boerse-global.de

The Munich-based holding company Mutares is navigating one of the most complex periods in its history, juggling a record-breaking acquisition with the urgent need to repair a balance sheet that breached its debt covenants. The tension between expansion and consolidation has weighed heavily on the stock, which at €24.85 trades just above its 52-week low and has shed roughly 17% of its value since the start of the year.

A Breach, a Waiver, and a Repayment Roadmap

The audited annual report for 2025, published on Tuesday, confirmed what the market had feared: Mutares violated the net debt-to-equity ratio agreed upon in its bond terms. The company attributed the breach to valuation effects, a slowdown in value-accretive transactions during the fourth quarter, and a sharp increase in leasing liabilities. Bondholders of the two Nordic issues — the 2023/27 and 2024/29 notes — granted a waiver, buying management time but not solving the underlying issue.

In response, the board has laid out a binding repayment schedule. Outstanding bonds stood at €385 million at the end of 2025, and Mutares aims to reduce that to between €250 million and €300 million by the close of 2026. The first tranche of buybacks is already in motion: at least €25 million of the 2023/27 bond will be retired in the current quarter, with a further €25 million earmarked for each subsequent quarter. The company expects to be back in compliance with its covenants by the end of June.

Record Revenue but an Adjusted EBITDA Still in the Red

Group revenue for 2025 climbed to €6.5 billion, up from €5.3 billion a year earlier, while holding-level net profit rose to €130.4 million. Consolidated EBITDA hit €675.3 million, boosted by bargain-purchase gains and exit proceeds. However, the adjusted EBITDA — a cleaner measure of underlying performance — remained negative at minus €31.2 million, though that marked a significant improvement from minus €85.4 million in the prior year.

Should investors sell immediately? Or is it worth buying Mutares?

Magirus in the Spotlight as Defence Sector Heats Up

To accelerate debt reduction, Mutares is exploring strategic options for Magirus, the firefighting and defence equipment subsidiary acquired in spring 2024. The portfolio company boasts an order backlog of well over €800 million, securing capacity deep into 2027. Management is also pushing ahead with the expansion of Magirus’s higher-margin defence business, a move analysts see as a clear signal that the company intends to capitalise on the current premium valuations in the defence sector — either through an initial public offering or a direct sale.

The SABIC Deal Reshapes the Portfolio

While one hand consolidates, the other is spending big. The recently signed acquisition of SABIC’s Engineering Thermoplastics business is the largest in Mutares’s history, adding roughly €2 billion in revenue and forming the backbone of a new specialty chemicals segment. The deal has prompted a revision of the company’s medium-term targets: the €10 billion revenue milestone, originally pencilled in for 2028, is now expected to be reached significantly earlier. For the remainder of the decade, Mutares is targeting annual group revenue growth of at least 25%.

US Expansion and a Capital Injection

Alongside the balance-sheet repair, Mutares is pressing ahead with its transatlantic ambitions. A capital increase completed in April 2026 raised gross proceeds of €105 million. The company already has a foothold in Chicago and is scouting for a second US location. The acquisition pipeline in North America currently includes targets with a combined revenue volume of around €4.8 billion.

Mutares at a turning point? This analysis reveals what investors need to know now.

What’s Next for Investors

The next major test comes on 12 May, when Mutares publishes its first-quarter results. Investors will be looking for concrete evidence that the debt reduction plan is on track. Then, on 3 July, the annual general meeting will vote on a proposed baseline dividend of €2.00 per share, with an additional performance dividend tied to significant exit proceeds.

For now, the stock remains under pressure, trading at €25.05 — roughly 22% below its level a year ago. The coming months will reveal whether Mutares can successfully balance its growth ambitions with the financial discipline the bond market demands.

Ad

Mutares Stock: New Analysis - 29 April

Fresh Mutares information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Mutares analysis...

So schätzen die Börsenprofis Mutares Aktien ein!

<b>So schätzen die Börsenprofis Mutares Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
FĂĽr. Immer. Kostenlos.
en | DE000A2NB650 | MUTARES | boerse | 69257953 |